Evidence map›Paper›PMID 37043828›Full record

ArticleAmerican journal of respiratory cell and molecular biology2023

Bridging the Gap between Innate and Adaptive Immunity in the Lung: Summary of the Aspen Lung Conference 2022.

Anuradha Ray, Sagar L Kale, Richard P Ramonell

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anuradha RayDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and.ORCID 0000-0001-6844-8918
Sagar L KaleDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and.
Richard P RamonellDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, and.ORCID 0000-0002-2385-0636
Pulmonary and Allergy Associates · USUniversity of Pittsburgh · US

Funding

Project 2 Impact of Innate and Adaptive Immunity At the Airway Epithelium in Severe AsthmaP01AI106684 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Anuradha Ray · 2015 to 2026
$18.9M
Translational Training Program in Pulmonary Biology and MedicineT32HL007563 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Melanie Koenigshoff · 1985 to 2026
$12.3M
MECHANISMS OF ANTIGEN INDUCED TOLERANCE IN THE LUNGR01AI048927 · NIAID · YALE UNIVERSITY · PI RAY, ANURADHA · 2001 to 2020
$8.0M
Mechanisms of lung macrophage programming by MUC5B during health and diseaseR01HL130938 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI EVANS, CHRISTOPHER M · 2016 to 2025
$5.2M
Understanding Severe Asthma Using an Experimental ModelR01HL113956 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAY, ANURADHA, RAY, PRABIR · 2013 to 2021
$3.5M
Dysregulated Immunometabolism and Premature Senescence in Corticosteroid-Refractory Severe AsthmaR35HL166219 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Anuradha Ray · 2023 to 2026
$2.9M
Aspen Lung Conference: Bridging the Gap between Innate and Adaptive Immunity in the LungR13HL164036 · NHLBI · NATIONAL JEWISH HEALTH · PI JANSSEN, WILLIAM, MAIER, LISA A · 2022 to 2022
$33k
NHLBI NIH HHS R01 HL113956NHLBI NIH HHS R01 HL130938NHLBI NIH HHS R13 HL164036NHLBI NIH HHS R35 HL166219NHLBI NIH HHS T32 HL007563NIAID NIH HHS P01 AI106684NIAID NIH HHS R01 AI048927
6 · The paper itself

Abstract

Although significant strides have been made in the understanding of pulmonary immunology, much work remains to be done to comprehensively explain coordinated immune responses in the lung. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic only served to highlight the inadequacy of current models of host-pathogen interactions and reinforced the need for current and future generations of immunologists to unravel complex biological questions. As part of that effort, the 64th Annual Thomas L. Petty Aspen Lung Conference was themed "Bridging the Gap between Innate and Adaptive Immunity in the Lung" and featured exciting work from renowned immunologists. This report summarizes the proceedings of the 2022 Aspen Lung Conference, which was convened to discuss the roles played by innate and adaptive immunity in disease pathogenesis, evaluate the interface between the innate and adaptive immune responses, assess the role of adaptive immunity in the development of autoimmunity and autoimmune lung disease, discuss lessons learned from immunologic cancer treatments and approaches, and define new paradigms to harness the immune system to prevent and treat lung diseases.

Indexed as

COVID-19Lung DiseasesAdaptive ImmunityHumansLungSARS-CoV-2adaptive immunityinnate immunitylung

Identifiers

PMID37043828
PMCPMC10503303
OpenAlexW4365138362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.